Releases Saturday 6 July 2002
No 7354 Volume 325

Please remember to credit the BMJ as source when publicising an
article and to tell your readers that they can read its full text on the
journal's web site (http://bmj.com).

If your story is posted on a website please include a link back to
the source BMJ article (URL's are given under titles).


(1) NEW SCREENING METHODS FOR DOWN'S
SYNDROME QUESTIONED

(2) UNDISCLOSED PAYMENTS TO DOCTORS
RECRUITING TRIAL PATIENTS IS UNETHICAL

(3) TRADITIONAL HEALING MAY RELIEVE
SYMPTOMS OF MENTAL ILLNESS

(4) SOUTH ASIAN PATIENTS ARE MISSING OUT
ON CHOLESTEROL DRUGS

(5) STUDIES OFTEN IGNORE DOMESTIC
VIOLENCE COMMITTED BY WOMEN



(1) NEW SCREENING METHODS FOR DOWN'S
SYNDROME QUESTIONED

(Retrospective audit of different antenatal screening
policies for Down's syndrome in eight district general
hospitals in one health region )
http://bmj.com/cgi/content/full/325/7354/15

New screening techniques for Down's syndrome are less
effective than previously supposed, despite a government
initiative to offer all pregnant women the new tests by
2004, finds a study in this week's BMJ.

Researchers identified all cases of Down's syndrome in
eight district general hospitals in the Wessex region
between 1994 and 1999. During these six years,
155,501 babies were delivered 335 cases of Down's
syndrome were identified.

Across the region, seven different screening policies were
used, in three principal groups: - serum screening -
screening by maternal age plus serum or nuchal screening
- screening by maternal age (35 years or more) combined
with routine anomaly scans

Fifteen per cent of pregnant women were aged over 35
years at delivery - more than double the 5-7% presumed
in statistical models of screening - and 58% of infants
with Down's syndrome were born to women in this age
range.

The team found no evidence that serum and nuchal
screening improves antenatal detection rates or reduces
rates of invasive procedure, such as amniocentesis. The
districts that used serum screening detected 57% of
cases, those using maternal age plus serum or nuchal
screening detected 52%, and those using a maternal age
of 35 or more and anomaly scans detected 54%.

Their findings also suggest that the recently announced
government initiative to introduce universal serum
screening from 2004 - to increase detection rates and
reduce the need for invasive procedures such as
amniocentesis - will not achieve its stated objectives.

"To avoid continuing the confusion that Down's screening
currently causes in pregnant women, we believe that new
screening methods should be offered only as part of a
controlled study until their benefit is proved," they
conclude.

Contacts:

Diana Wellesley, Associate Specialist in Clinical
Genetics, Wessex Clinical Genetics Service, Princess
Anne Hospital, Southampton, UK
Email: dgw@soton.ac.uk

or

David Howe, Consultant in Fetomaternal Medicine,
Wessex Fetal Medicine Unit, Princess Anne Hospital,
Southampton, UK

(2) UNDISCLOSED PAYMENTS TO DOCTORS
RECRUITING TRIAL PATIENTS IS UNETHICAL

(Ethics of undisclosed payments to doctors recruiting
patients in clinical trials)
http://bmj.com/cgi/content/full/325/7354/36

Doctors are often paid to recruit patients to clinical trials
sponsored by pharmaceutical companies, yet such
payments are often not disclosed to the patients.
Researchers in this week's BMJ argue that this practice is
unethical and damages efforts to involve patients more
fully in clinical trials.

Over the years, payments have soared to thousands of
pounds per completed patient, and well- organised
British general practices can earn an extra £15,000
annually for three hours' work a week, write the authors.
As a result, trials designed by non-commercial sponsors
aiming to answer clinically important questions, but
without the funding available to pay recruiters, fail to
attract doctors.

Although guidelines insist that such payments are divulged
to a research ethics committee, commercial sponsors
regularly flout these recommendations, they add.

Patients believe that such payments are wrong and that
they have a right to be told about them, say the authors.
Furthermore, a change to the regulatory framework
making full disclosure mandatory would not meet with
opposition.

"Consent obtained on the basis of withholding information
on an issue that patients consider important is not fully
informed consent. If we are ever to reach the ideal of
involving patients in the design and conduct of clinical
trials then we could do worse than treat patients as equal
partners by making full and frank disclosure of payments
that trial sponsors make to doctors for recruiting their
patients," they conclude.

Contact:

Jammi N Rao, Director of Public Health, North
Birmingham Primary Care Trust, Birmingham, UK
Email: jammi@bharat.demon.co.uk

(3) TRADITIONAL HEALING MAY RELIEVE
SYMPTOMS OF MENTAL ILLNESS

(Traditional community resources for mental health: a
report of temple healing from India)
http://bmj.com/cgi/content/full/325/7354/38

Temple healing practices may help to improve the
symptoms of people with mental illnesses, according to
researchers in this week's BMJ.

The study was conducted at the temple of Muthuswamy
in South India, known as a source of help for people with
serious mental disorders. From June to August 2000,
everyone who came for help was assessed by a trained
psychiatrist on the first day of their stay in the temple and
again on the day they left to return home, using
recognised psychiatric rating scale scores. Family
caregivers were also asked to assess satisfaction with
their experience at the temple.

A total of 31 people sought help and stayed at the
temple. Twenty three were diagnosed with paranoid
schizophrenia, six with delusional disorders, and two with
bipolar disorder. No specific ceremonies to promote the
recovery of patients are performed at the temple. Instead
the patient is encouraged to take part in the daily
maintenance routines of the temple.

The researchers found a reduction of nearly 20% in
psychiatric rating scale scores, representing a level of
clinical improvement that matches that achieved by many
psychotrophic drugs. Family caregivers also thought that
most of the patients had improved during their stay.

In the absence of any specific healing rituals, the
observed benefits appeared to result from a supportive,
non-threatening environment, say the authors. They
suggest that these institutions may have a role in providing
community mental health care.

Contact:

R Raguram, Professor of Psychiatry, National Institute of
Mental Health and Neurosciences, Bangalore, India
Email: raguram@nimhans.kar.nic.in

(4) SOUTH ASIAN PATIENTS ARE MISSING OUT
ON CHOLESTEROL DRUGS

(Prescribing of lipid lowering drugs to South Asian
patients: ecological study)
http://bmj.com/cgi/content/full/325/7354/25

Patients in general practices with a greater South Asian
population are less likely to be prescribed cholesterol
lowering drugs, despite being at a higher risk of coronary
heart disease than white patients, finds a study in this
week's BMJ.

Researchers identified the proportion of South Asian
patients at 62 general practices in one health authority in
England. They then determined the number of daily doses
of all cholesterol lowering drugs prescribed to these
patients.

They found that patients in practices with a greater South
Asian population were less likely to receive cholesterol
lowering drugs.

It was not possible for the authors to ascertain the
incidence of coronary heart disease in the practices
studied. However, this finding is surprising, they say,
given the higher level of cardiovascular illness and death
among South Asian people in the UK, and an equal if not
greater need for cholesterol lowering treatment than the
white population.

Further analysis is needed to ascertain the effects of
subsequent prescribing guidelines and recent government
strategies promoting the use of cholesterol lowering
drugs, say the authors. Assessment to determine the
extent of unmet need and risk profiles at the level of the
individual patient, with particular reference to South Asian
patients, is also required.

Contacts:

Mahendra Patel, Research Assistant in Pharmacy
Practice, School of Pharmacy, University of Bradford,
Bradford, UK
Email: m.g.patel@bradford.ac.uk

or

David Wright, Lecturer in Pharmacy Practice

or

Paramijit Gill, Clinical Senior Lecturer, Department of
Primary Care and General Practice, University of
Birmingham, Birmingham, UK

(5) STUDIES OFTEN IGNORE DOMESTIC
VIOLENCE COMMITTED BY WOMEN

(Letters: Domestic Violence)
http://bmj.com/cgi/content/full/325/7354/44

It's not only men who commit domestic violence, yet
scientific studies rarely look at female-to-male violence,
according to two letters in this week's BMJ.

Responding to a recent editorial on domestic violence, Dr
Mark Horner argues that the clear implication is that men
are the oppressors and women suffer. Sadly this is often
true, but it is far from being the whole picture, he writes.

According to the 1996 British crime survey on the extent
of domestic violence in England and Wales, 4.2% of
women and 4.2% of men said that they had been
physically assaulted by a current or former partner in the
past year.

Indeed, when one considers that most violence against
children is committed by women, in terms of gender it is
women who are most likely to be perpetrators of
domestic violence, says the author. Why is domestic
violence so often portrayed in such a partisan and
unscientific way?

The justification for this slant in the domestic violence
literature has been that female victims vastly outnumber
male victims, writes Dr Chris Carlsten in an
accompanying letter. Many data however suggest
otherwise.

For example, one study found that 86% of marital
aggression was reported as reciprocal between husbands
and wives. Another found that female-to-male violence
was reported to be higher than male-to-female.

Such reporting bias ignores many thousands of male
victims and alienates those who demand a more balanced
presentation, says the author. "Let's keep working to get
better data, but let's recognise the bi-gender nature of this
societal ill," he concludes.

Contact:

Chris Carlsten, Resident in Internal Medicine,
Department of Medicine, University of Washington,
Seattle, USA
Email: carlsten@u.washington.edu


FOR ACCREDITED JOURNALISTS

Embargoed press releases and articles are available from:

Public Affairs Division
BMA House
Tavistock Square
London WC1H 9JR
(contact: pressoffice@bma.org.uk)

and from:

the EurekAlert website, run by the American Association for the
Advancement of Science
(http://www.eurekalert.org)